What you must know:

– Thyme Care, a number one value-driven most cancers care enabler, raises $95 million in financing led by Harmony Well being Companions, with participation from current traders together with CVS Well being® Ventures, City Corridor Ventures, a16z Bio+Well being, AlleyCorp, Echo Well being Ventures, Foresite Capital and new investor SignalFire. The financing brings Thyme Care’s complete funding to $178 million.

– Thyme Care is a value-driven most cancers care facilitator centered on bettering affected person outcomes and decreasing healthcare prices. The brand new funding will gas Thyme Care’s growth into new markets, deepen current partnerships and improve its scientific value-driven care mannequin.

Tackling the disaster in most cancers care

The most cancers care panorama is characterised by rising prices, fragmented care, and important disparities in affected person outcomes. Drug prices alone can account for as much as 70% of complete healthcare prices, with many life-saving therapies costing greater than $200,000 yearly. Sufferers usually face overwhelming monetary burdens, gaps in assist, and a scarcity of care coordination.

Thyme Care addresses these challenges with a complete strategy centered on decreasing prices, bettering outcomes and enhancing the affected person expertise.

Thyme Care's impactful resolution

Thyme Care's value-driven care mannequin consists of:

• 24/7 specialised navigation for most cancers care: Guiding sufferers by way of advanced remedy processes.
• Superior expertise and information insights: Optimizing healthcare provision and figuring out areas for enchancment.
• Caregiver-led therapeutic interventions: Guaranteeing that sufferers obtain the absolute best care.

By implementing these methods, Thyme Care achieved a $594 discount in month-to-month prices for managed sufferers in comparison with a management group.

Partnerships and monetary duty

Thyme Care has established robust partnerships with Medicare Benefit and business payers, and participates in CMS’s Enhancing Oncology Mannequin (EOM), permitting the corporate to take monetary danger for oncology populations, scale back prices and enhance outcomes.

Thyme Care additionally developed the Thyme Care Oncology Companion (TCOP) program to assist supplier practices. By providing digital care supply providers and analytics, TCOP helps practices scale back administrative burden, enhance effectivity, and reach value-based care preparations.

Speedy development and growth

Thyme Care is experiencing speedy development, actively managing greater than half a billion {dollars} in medical spend underneath risk-based contracts. The corporate goals to triple this determine throughout the subsequent yr. As well as, Thyme Care has greater than doubled its oncology partnerships previously six months and plans to increase its attain throughout america.

“Our newest funding is a testomony to the dedication and experience of our unbelievable crew, whose tireless efforts are propelling our mission to advance the most cancers care expertise,” stated Robin Shah, co-founder and CEO of Thyme Care. “We’re extremely grateful for the steadfast assist and collaboration of traders, suppliers and payer companions, whose dedication makes Thyme Care’s distinctive, provider-centric strategy potential. Collectively, we’re reshaping the panorama of oncology, delivering higher care and affordability for all.”